Analytical 360 in the News
- 05/17/2013 – The Seattle Times – “Pot rules taking shape; public gets a taste of what’s ahead”
- 04/26/2013 – NBC News – “Moldy marijuana? Legal markets spark push for health, safety standards”
- 04/24/2013 – The Stranger – “The State Says This Pot Isn’t Technically ‘Marijuana’”
- 04/24/2013 – Associated Press – “Officials: Legal marijuana law jeopardizes all pot prosecutions”
- 04/18/2013 – Associated Press – “VIDEO: For Wash. government bean-counter, a pot education”
- 04/18/2013 – Associated Press – “For Wash. government bean-counter, a pot education”
- 04/08/2013 – NPR – “For regulators, legalizing pot all about ‘getting into the weeds’”
- 03/06/2013 – Northwest Leaf – “Cannabis Testing”
- 02/20/2013 – Seattle Met Magazine – “Wait, How High Am I?”
- 02/08/2013 – KOMO 4 News – “No protection for medical marijuana users under new law”
Who We Are
Analytical 360′s dynamic team of biochemists, laboratory technicians, and friendly, courteous staff are dedicated to ensuring that patients using therapeutic cannabinoids have access to important information about the potency and safety of their medicine.
Using advanced equipment and well established published techniques, we provide dry-weight quantification, potency testing, cannibinoid profiling, foreign material detection and microbial bioburden screening. Analytical 360 safety-certifies medical cannabis for the protection, education and empowerment of patients.
We employ High Performance Liquid Chromatography (HPLC) technology to determine the original composition of cannabinoids present by direct analysis of plant and edible samples. This technique uniquely determines all of the medicinal components contained within the products and provides a cannibinoid profile in order to more accurately evaluate potency, institute material quality assurance and to identify plant phenotype.
Dr. Lara Taubner holds a Bachelors of Science in Chemistry and a PhD in Biochemistry from Montana State University. Throughout her 20 years working in science, she has gained industry, academic, and government laboratory experience, utilizing a wide variety of techniques including Organic Synthesis, TLC, HPLC, Mass Spectrometry, and Nuclear Magnetic Resonance. She has experience in cloning technology as well as the production, isolation, and high resolution characterization of bio-molecules. She has been extensively published in peer-reviewed scientific journals. Most recently, Lara finished a postdoctoral fellowship at the National Institute of Health. There she was part of a team that developed an assay to detect minute amounts of infectious materials that cause Mad Cow Disease for which she was awarded the National Institute of Health Director’s Award.
Randall Oliver holds degrees in Biology and Business. He brings twenty years of experience in research and development to Analytical 360. Randall’s expertise includes isolating and characterizing molecules from natural sources using a variety of techniques including Filtration, Chromatography, Light Scattering, Fluorescence, UV Spectroscopy, Mass Spectroscopy, and Crystallography. As a scientist in the pharmaceutical industry, Randall’s most recent endeavor was part of a team that developed methods to manufacture and quantify adjuvants for next generation malaria and cancer vaccines.
John Brown has 20 years experience as an IT Professional, working with high profile companies and successful “bleeding-edge” technologies in Dot-Com, Telecommunications, Financial, and Security industries. He brings to Analytical 360 his vast expertise in Data Analysis, Database Development, Software Development, Web Development, System Administration, Network Engineering, Security, and Scalability.
Patients using therapeutic cannabinoids in the Pacific Northwest deserve assurance that the herbal medicines recommended to them by doctors meet the same standard for effective, safe and reliable treatment as traditional pharmaceuticals.
By providing information on dosage, strain verification, and safety, Analytical 360 strives to safeguard the health and wellbeing of these patients.
Equipment, Processes & Validation of Methods
Analytical 360 is a state-of-the-art Cannabis Analysis Laboratory equipped with cutting edge, High Performance Liquid Chromatography (HPLC) technology. This machinery enables our team of biochemists to measure the potency of samples with far superior precision and efficiency than gas chromatography.
We use HPLC methodology in line with laboratory standards and practices within the wider national and international medical cannabis community and acknowledge the obvious advantages that HPLC technology holds over gas chromatography for accurate cannabinoid profiling. We employ established practices in conjunction with tightly controlled scientific procedures to produce test results that are precise, can be replicated and are independently verifiable.
Our tests procedures are designed by biochemists and involve methodology developed through decades of research and experimentation in isolating and characterizing molecules from natural source materials.